Skip to main content
Caplight Logo









Skin + Me

Skin + Me

Private
LondonHealthcare & Life Scienceshttps://www.skinandme.com/

Last Round

Series B

Feb 15, 2023

Total Funding Raised

$27.71M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Skin + Me is a digital health and skincare company that provides personalized, prescription-based skincare treatments through online dermatology consultations.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Subscription Commerce, D2C Brands, Fashion & Beauty, Personalization

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

personalized skincareprescription skincareteledermatologyskincare subscriptionDTC skincareonline dermatologistacne treatmentcustom skincarerosacea treatmentanti-aging skincaretelemedicinehyperpigmentation treatmentbeauty techTretinoinAzelaic Acid

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Skin + Me Comparables

Compare Skin + Me with similar companies based on industry and business-model similarity.

Skin + Me comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HeliosX
89%
ZipHealth Services Inc.
85%
Klira
85%

Skin + Me Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 15, 2023
SeedSep 16, 2019
SeedMay 28, 2019

Key People

Founding team and executive leadership

Horatio Cary

Co-Founder & CEO

Founding Team

Nora J.

Chief Executive Officer

Executive Team

Joel Stephens

Group Chief Financial Officer

Executive Team

Skin + Me Investors

Notable investors and investment history

Skin + Me investors
InvestorRounds
Tekton VenturesSeed
Repeat VenturesSeries B, Seed
Samos InvestmentsSeed
Jigsaw VCSeed
Octopus InvestmentsSeed
JamJar InvestmentsSeries B, Seed
Octopus VenturesSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Launched Renew + Me, a prescription skincare brand for women 45+.

  • Jun 17, 2026

    Launched Hair + Me, a prescription-led hair health treatment.

Skin + Me Filings

Explore SEC and related filing metadata, where available.

Skin + Me filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Skin + Me's valuation, stock price, and market status.

Is Skin + Me a public or private company?

Skin + Me is a private company.

What is the current stock price of Skin + Me?

Skin + Me is a private company with no public stock price. No recent secondary market data is available.

How much is Skin + Me worth (valuation)?

Valuation information for Skin + Me is not publicly available.

Can I buy Skin + Me stock?

Skin + Me shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Skin + Me's last funding round?

Skin + Me's most recent funding round was Series B on February 15, 2023.

Who are the main investors in Skin + Me?

Key investors in Skin + Me include Octopus Ventures.

Will Skin + Me IPO soon?

No public IPO plans have been announced for Skin + Me.

How can I track Skin + Me secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Skin + Me's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range132
Year Founded2018
Last FundingFeb 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?